Steven Charochak
Family Medicine · Kansas City, MONPI 1104821818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $449 and has fallen 90.1% since, to $44 in 2022.
Across 73 payments — averaging $13.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$186
- Sanofi-aventis U.S. LLC$136
- AbbVie$94
- Amarin Pharma, Inc.$75
- Biohaven Pharmaceuticals, Inc.$70
- Novo Nordisk$69
- plus $328 from 15 others
What the payments were for
- Food & beverage$958100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 19 | $186 |
| Sanofi-aventis U.S. LLC | 9 | $136 |
| AbbVie(2 entities) | 7 | $94 |
| Amarin Pharma, Inc. | 5 | $75 |
| Biohaven Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk | 5 | $69 |
| Astellas Pharma US Inc | 3 | $38 |
| GSK | 3 | $34 |
| Novartis | 3 | $34 |
| Neos Therapeutics, LP | 2 | $31 |
| Johnson & Johnson | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Amgen | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$958 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.